Can ranitidine be administered intravenously?

Yes, ranitidine can be administered intravenously.

Ranitidine is FDA-approved for intravenous administration and can be given via three distinct IV routes: intermittent bolus injection, intermittent infusion, or continuous infusion 1.

IV Administration Methods

Intermittent Bolus

• Dose: 50 mg (2 mL) every 6-8 hours
• Preparation: Dilute in 0.9% sodium chloride or compatible IV solution to concentration ≤2.5 mg/mL (20 mL total volume)
• Rate: Inject over 5 minutes (no faster than 4 mL/min)
• This is the most common method used in clinical practice 1

Intermittent Infusion

• Dose: 50 mg (2 mL) every 6-8 hours
• Preparation: Dilute in 5% dextrose or compatible solution to concentration ≤0.5 mg/mL (100 mL total volume)
• Rate: Infuse over 15-20 minutes (5-7 mL/min)
• Superior efficacy: Continuous infusion methods are significantly more effective than bolus injections for maintaining gastric pH >4.0 2, 3

Continuous Infusion

• Standard dose: 6.25 mg/hour (150 mg in 250 mL at 10.7 mL/hour)
• For Zollinger-Ellison: Start at 1.0 mg/kg/hour, titrate up in 0.5 mg/kg/hour increments as needed
• Maximum concentration: 2.5 mg/mL
• Continuous infusion provides the most consistent acid suppression with less pH fluctuation compared to bolus dosing 2, 3

Pediatric Dosing

• Total daily dose: 2-4 mg/kg divided every 6-8 hours
• Maximum single dose: 50 mg every 6-8 hours
• Neonates (<1 month on ECMO): 2 mg/kg every 12-24 hours or as continuous infusion 1

Renal Impairment

• CrCl <50 mL/min: 50 mg every 18-24 hours (may increase to every 12 hours with caution)
• Time dosing to coincide with end of hemodialysis when applicable 1

Clinical Context: Anaphylaxis Management

In anaphylaxis treatment, ranitidine 50 mg in adults (12.5-50 mg or 1 mg/kg in children) should be diluted in 5% dextrose to 20 mL total volume and injected IV over 5 minutes 4. However, critical caveats apply:

• Ranitidine is second-line therapy only - never use without epinephrine
• Combination of diphenhydramine plus ranitidine is superior to diphenhydramine alone
• Much slower onset than epinephrine; does not replace it 4

Critical Safety Warning

Rapid IV bolus administration without proper dilution has been associated with cardiac arrest 5. In a case series, all patients who experienced cardiac arrest received ranitidine as fast IV bolus without dilution, with arrest occurring within 20 minutes. From WHO global database analysis, 185 cases of cardiac arrest were reported with ranitidine, 49.7% fatal 5.

To prevent cardiac arrest:

• Always dilute before IV administration
• Never give as rapid undiluted bolus
• Follow the 5-minute injection time for bolus dosing
• Use proper concentration limits (≤2.5 mg/mL for bolus, ≤0.5 mg/mL for infusion)

Stability

• Stable for 48 hours at room temperature when diluted in common IV solutions (0.9% NaCl, D5W, D10W, lactated Ringer's)
• Yellow discoloration may intensify over time without affecting potency 1, 6

Efficacy Considerations

Continuous infusion is pharmacodynamically superior to bolus dosing for maintaining therapeutic effect. Studies show continuous infusion maintains gastric pH >4.0 in 75-83% of measurements, while bolus injections cause wide pH fluctuations (7.6 to 1.6) 2. The median effective concentration (EC50) is approximately 45 ng/mL, achieved 35-50 minutes after administration 3.

Note: Ranitidine was withdrawn from the US market in 2020 due to NDMA contamination concerns, though the question addresses its technical administration capabilities.